ERT is commonly used to treat lysosomal storage disorders such as Gaucher disease, Fabry disease, and Pompe disease. These disorders are caused by mutations in genes encoding lysosomal enzymes, leading to the accumulation of substrates that are normally degraded by these enzymes. By providing the missing enzyme, ERT helps to clear these substrates and alleviate disease symptoms.
